ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.909,14
-0,25%
S&P 500
5.890,39
-1,35%
Dow Jones
42.403,48
-1,37%
Euro vs US Dollar
1,03906
-0,37%
Bitcoin
91.935,86
-1,68%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Rani Therapeutics Holdings Inc (RANI) Börsenkurse

Rani Therapeutics Holdings Inc

Rani Therapeutics Holdings Inc (RANI)

NASDAQ
1,39
-0,04
( -2,80% )
Aktualisiert: 16:21:05
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
1,39
Gebot
1,38
Fragen
1,39
Volumen
59.449
1,35 Tagesbereich 1,40
1,30 52-Wochen-Bereich 8,75
Marktkapitalisierung
79,631M
Handelsende
1,43
Handelsbeginn
1,3818
Letzte Trade
1
@
1.385
Letzter Handelszeitpunkt
16:25:22
Finanzvolumen
US$ 81.860
VWAP
1,377
Durchschnittliches Volumen (3 Mio.)
2.039.961
Ausgegebene Aktien
57.288.682
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,34
Gewinn pro Aktie (EPS)
-0,59
Erlöse
-
Nettogewinn
-33,97M

Über Rani Therapeutics Holdings Inc

Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injecti... Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.ranitherapeutics.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Rani Therapeutics Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RANI. The last closing price for Rani Therapeutics was US$1,43. Over the last year, Rani Therapeutics shares have traded in a share price range of US$ 1,30 to US$ 8,75.

Rani Therapeutics currently has 57.288.682 shares in issue. The market capitalisation of Rani Therapeutics is US$81,92 million. Rani Therapeutics has a price to earnings ratio (PE ratio) of -2.34.

RANI Neueste Nachrichten

Weitere Nachrichten

Form 4 - Statement of changes in beneficial ownership of securities

17 Dezember 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

17 Dezember 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

17 Dezember 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

10 Dezember 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

14 November 2024
Edgar (US Regulatory)

Form 8-K - Current report

14 November 2024
Edgar (US Regulatory)

Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update

- Completed two equity offerings with total gross proceeds of approximately $20.0 million; cash runway extended into 3Q 2025 - - Announced new preclinical pharmacokinetic data supporting...

14 November 2024
GlobeNewswire Inc.

Rani Therapeutics to Participate in Upcoming Investor Conferences

SAN JOSE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...

07 November 2024
GlobeNewswire Inc.

Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist

-Transenteric delivery of incretin triagonist GLP-1, GIP, glucagon receptors mimicking the RaniPill route of administration elicits rapid weight loss and bioavailability comparable to subcutaneous...

17 Oktober 2024
GlobeNewswire Inc.

Form 8-K - Current report

16 Oktober 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.01-0.7142857142861.41.5151.354149441.42276957CS
4-0.64-31.52709359612.032.041.35296321.62817814CS
12-0.93-40.08620689662.323.751.320399612.65857405CS
26-2.43-63.6125654453.824.191.39680032.6645578CS
52-1.93-58.13253012053.328.751.35439942.91646161CS
156-16.92-92.408519934518.3127.131.32174193.66584656CS
260-9.87-87.655417406711.2636.271.32149235.49313105CS

RANI - Frequently Asked Questions (FAQ)

What is the current Rani Therapeutics share price?
The current share price of Rani Therapeutics is US$ 1,39
How many Rani Therapeutics shares are in issue?
Rani Therapeutics has 57.288.682 shares in issue
What is the market cap of Rani Therapeutics?
The market capitalisation of Rani Therapeutics is USD 81,92M
What is the 1 year trading range for Rani Therapeutics share price?
Rani Therapeutics has traded in the range of US$ 1,30 to US$ 8,75 during the past year
What is the PE ratio of Rani Therapeutics?
The price to earnings ratio of Rani Therapeutics is -2,34
What is the reporting currency for Rani Therapeutics?
Rani Therapeutics reports financial results in USD
What is the latest annual profit for Rani Therapeutics?
The latest annual profit of Rani Therapeutics is USD -33,97M
What is the registered address of Rani Therapeutics?
The registered address for Rani Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Rani Therapeutics website address?
The website address for Rani Therapeutics is www.ranitherapeutics.com
Which industry sector does Rani Therapeutics operate in?
Rani Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
WATTEnergous Corporation
US$ 1,60
(289,11%)
110,39M
NXUNXU Inc
US$ 0,7995
(228,47%)
212,05M
INTZIntrusion Inc
US$ 6,24
(188,89%)
88,11M
VINCVincerx Inc
US$ 0,455
(134,54%)
197,59M
HOLOMicroCloud Hologram Inc
US$ 4,17
(73,75%)
63,71M
ABPAbpro Holdings Inc
US$ 2,4377
(-45,71%)
503,59k
TRAWTraws Pharma Inc
US$ 8,315
(-38,04%)
744,54k
LITMSnow Lake Resources Ltd
US$ 1,1809
(-26,19%)
34,45M
BITSGlobal X Blockchain and Bitcoin Stratagy ETF
US$ 65,8599
(-25,55%)
5,08k
LICNLichen China Limited
US$ 0,1797
(-22,58%)
21,76M
NXUNXU Inc
US$ 0,7995
(228,47%)
212,05M
VINCVincerx Inc
US$ 0,455
(134,54%)
197,59M
XTIAXTI Aerospace Inc
US$ 0,03975
(0,63%)
110,5M
WATTEnergous Corporation
US$ 1,60
(289,11%)
110,39M
INTZIntrusion Inc
US$ 6,24
(188,89%)
88,11M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
RANI
Rani Therapeutics
USOTC
GBDMF
Global Dominion Access (PK)
BIT
NSCIT1639839
IBRD
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten